Sandoz Opens New Biosimilar Production Center in Slovenia

MT Newswires · 2d ago
01:41 AM EDT, 09/29/2026 (MT Newswires) -- Sandoz Group (SDZ.SW) launched a biosimilar drug substance production center in Lendava, Slovenia. The new facility supports the Swiss drugmaker's Bio100 strategy, under which it aims to build a portfolio of more than 100 biosimilars by 2040, according to a Tuesday release. The facility will use smart automation and process analytical technology and employ over 300 people.